Skip to content

Exploratory factor and network analysis of 43 inflammatory plasma biomarkers and cognitive performance in Black adults

Sep 2026 · Journal of Alzheimer's Disease · Vol 113, pp. 1758 - 1771 · 0 citations · 67 references
Medicine

TL;DR

Exploratory factor analysis (EFA) identified clusters of correlated inflammatory biomarkers associated with cognitive performance in this cohort of midlife and older adults.

Abstract

Background Systemic inflammation has been implicated in cognitive aging and neurodegeneration; however, inflammatory biomarkers are expressed in coordinated patterns rather than as isolated markers. Objective To identify latent inflammatory biomarker groupings and evaluate their associations with cognitive performance among midlife and older adults. Methods This cross-sectional study included 334 participants from the Aging Research Characterizing Health Exposome via Social Drivers (ARCHES) study. Cognitive performance was assessed using the Preclinical Alzheimer Cognitive Composite (PACC). Plasma inflammatory biomarkers were quantified using the NuLISA™ multiplex immunoassay platform. Exploratory factor analysis (EFA) (minimum residual extraction, oblimin rotation) identified latent inflammatory factors, retaining biomarkers with loadings ≥0.40. Factor scores were evaluated in multivariable linear regression models adjusted for age, sex, education, and genotype status; sensitivity analyses adjusted for socioeconomic context, medication use, BMI, lifestyle factors, and clinical diagnoses. Age-stratified and nonlinear spline analyses were conducted. Results 27 of 43 biomarkers formed an eight-factor structure explaining 43% of variance. Two factors were significantly associated with cognitive performance after FDR correction. Factor 4 (CCL4, CXCL1, S100A12) and Factor 5 (IL2, IL5, IL13, IL10, CSF2) were inversely associated with PACC scores. These associations remained consistent across sensitivity analyses. Age-stratified analyses showed that several inflammatory factors were associated with cognitive performance among participants aged 45–<65 years, whereas no factors remained significant among participants aged ≥65 years after FDR correction. Nonlinear modeling indicated a non-linear age-cognitive performance relationship. Conclusions EFA identified clusters of correlated inflammatory biomarkers associated with cognitive performance in this cohort of midlife and older adults.

View source

Similar papers

Open access Sep 2026

Serum biomarkers, modifiable risk factors, cognition, and processing speed in older adults.

Serum creatinine levels and depressive symptoms were independently associated with global cognition and processing speed and diabetes was independently associated with processing speed.

Chia-Te Chen, Fong-Ping Tang, Chia-Hao Fan et al. · 0 citations
Review Sep 2026

Roles of smoke exposure and inflammatory biomarkers in cognitive function among older adults: Findings from two prospective cohort studies

Background Many studies have established associations between smoke exposure and both accelerated cognitive decline and systemic inflammation. However, their interrelationship remains unclear. Objective This study aims to provide novel insights into the tripartite relationships linking smoke exposure, inflammatory biom...

Xin Yang, Xiang-Chun Xu, Ying Liu et al. · 0 citations
Open access Sep 2026

Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

In CSF-confirmed participants, age emerged as the most consistent predictor of plasma biomarker levels, particularly NFL and pTau181, which suggests that plasma biomarkers are influenced primarily by age and genetic background rather than by metabolic factors in this cohort.

Carolin I. Kurz, Marleen Taute, Paulina Tegethoff et al. · 0 citations
Open access Sep 2026

Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease

CSF proteomics revealed stronger APOEε4 and amyloid‐associated analyte signatures than plasma, and CSF inflammatory signaling, particularly eotaxin‐1, may serve as a correlate of longitudinal cognitive decline in cognitively normal older adults at risk for AD.

Jagan A. Pillai, Audrey Zhu, Chun-Xuan Ma et al. · 0 citations
Open access Oct 2026

Systemic inflammation, gut microbiome composition, and cognitive performance among older Ugandans with Alzheimer’s disease and related dementias

Systemic inflammation is implicated in neurodegeneration; however, evidence linking circulating inflammatory biomarkers to cognitive decline remains inconsistent, particularly in low- and middle-income countries. High-sensitivity C-reactive protein (hs-CRP) is a standard systemic inflammatory marker; however, its relat...

Kamada Lwere, N. Nakasujja, H. Muwonge et al. · 0 citations
Open access Oct 2026

Exploratory Factor Analysis Defined Allostatic Load Indices and Cognition Among Older Adults: Variation Across Race and Sex

Objective: Allostatic load (AL), a measure of cumulative biological dysregulation, is associated with negative cognitive outcomes. This study employed a data-driven approach to construct AL indices from multiple biomarkers and examined their associations with cognition among older adults, as well as whether these ass...

Mubarick Saeed, Charles F. Murchison, D. Geldmacher et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.